|
Index of reports
> Cases with Nausea (89)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone where reactions include nausea. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 89 Next >>
Possible Prednisone side effects in female
Reported by a physician from Sweden on 2012-08-20
Patient: female
Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine
Dosage: 150 mg/day
Administration route: Oral
Indication: Polymyositis
Cyclophosphamide
Dosage: 100 mg/day
Administration route: Oral
Indication: Polymyositis
Methotrexate
Dosage: 20 mg/week
Indication: Polymyositis
Methylprednisolone
Prednisone
Dosage: 40 mg/day
Indication: Polymyositis
Prednisone
Dosage: 2.5 mg/day
Prednisone
Dosage: 10mg daily
Prednisone
Dosage: 60 mg/day
Prednisone
Dosage: 17.5 mg/day
Administration route: Oral
Possible Prednisone side effects in female
Reported by a physician from Sweden on 2012-08-20
Patient: female
Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine
Dosage: 150 mg/day
Administration route: Oral
Indication: Polymyositis
Cyclophosphamide
Dosage: 100 mg/day
Administration route: Oral
Indication: Polymyositis
Methotrexate
Dosage: 20 mg/week
Indication: Polymyositis
Methylprednisolone
Prednisone
Dosage: 10mg daily
Prednisone
Dosage: 17.5 mg/day
Administration route: Oral
Prednisone
Dosage: 60 mg/day
Prednisone
Dosage: 2.5 mg/day
Prednisone
Dosage: 40 mg/day
Indication: Polymyositis
Possible Prednisone side effects in female
Reported by a physician from Sweden on 2012-08-20
Patient: female
Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine
Dosage: 150 mg/day
Administration route: Oral
Indication: Polymyositis
Cyclophosphamide
Dosage: 100 mg/day
Administration route: Oral
Indication: Polymyositis
Methotrexate
Dosage: 20 mg/week
Indication: Polymyositis
Methylprednisolone
Prednisone
Dosage: 40 mg/day
Indication: Polymyositis
Prednisone
Dosage: 10mg daily
Prednisone
Dosage: 17.5 mg/day
Administration route: Oral
Prednisone
Dosage: 60 mg/day
Prednisone
Dosage: 2.5 mg/day
Possible Prednisone side effects in 74 year old male
Reported by a physician from United States on 2012-08-03
Patient: 74 year old male, weighing 89.7 kg (197.3 pounds)
Reactions: Dyspnoea, Fatigue, Syncope, Nausea, Diarrhoea, Wheezing, Hypoxia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amoxicillin
Start date: 2012-05-04
Amoxicillin
Dosage: patinet took every 4 hours by mistake
Bevacizumab
Dosage: dose/frequency- 15 mg/kg over 30-90 min on day 1 of a cycle
Indication: Prostate Cancer
Start date: 2010-07-27
Docetaxel
Docetaxel
Dosage: frequency- 75 mg/m2 over 60 min on day 1 of a cycledocetaxel was held for cumulative toxicities
Indication: Prostate Cancer
Start date: 2010-07-27
Lenalidomide
Administration route: Oral
Indication: Prostate Cancer
Start date: 2010-07-27
Prednisone
Administration route: Oral
Indication: Prostate Cancer
Start date: 2010-07-27
Possible Prednisone side effects in female
Reported by a physician from Poland on 2012-08-02
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Retroperitoneal Mass, Vomiting, Nausea, Anaemia, Nephropathy Toxic, Folate Deficiency, Iron Deficiency, Herpes Zoster, Vitamin B12 Increased, Asthenia, Beta 2 Microglobulin Increased, Leukopenia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Doxorubicin Hydrochloride
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Prednisone
Administration route: Oral
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Vincristine
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Other drugs received by patient: Heviran; Tamoxifen Citrate
Possible Prednisone side effects in
Reported by a physician from United States on 2012-08-01
Patient:
Reactions: Nausea, Motor Dysfunction, Pain, Rash, Peripheral Sensory Neuropathy, Fatigue, Dyspepsia, Blood Potassium Decreased, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Waldenstrom's Macroglobulinaemia
Cyclophosphamide
Dosage: on day 1
Indication: B-Cell Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Lymphocytic Lymphoma
Cyclophosphamide
Dosage: on day 1
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Waldenstrom's Macroglobulinaemia
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Lymphoma
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: non-Hodgkin's Lymphoma
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Lymphocytic Lymphoma
Doxorubicin Hydrochloride
Dosage: on day 1
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: B-Cell Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: B-Cell Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: Waldenstrom's Macroglobulinaemia
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: Lymphocytic Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Rituximab
Dosage: maintenance
Indication: Waldenstrom's Macroglobulinaemia
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Indication: Lymphocytic Lymphoma
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Rituximab
Dosage: on day 1
Indication: B-Cell Lymphoma
Rituximab
Dosage: on day 1
Indication: non-Hodgkin's Lymphoma
Rituximab
Dosage: maintenance
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Indication: Lymphoma
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Indication: non-Hodgkin's Lymphoma
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: B-Cell Lymphoma
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: Lymphoma
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Indication: Lymphocytic Lymphoma
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: Waldenstrom's Macroglobulinaemia
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Waldenstrom's Macroglobulinaemia
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Lymphocytic Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: B-Cell Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Lymphoma
Other drugs received by patient: Diphenhydramine HCL; Acetaminophen; Ondansetron
Possible Prednisone side effects in male
Reported by a consumer/non-health professional from Brazil on 2012-07-31
Patient: male
Reactions: Abdominal Discomfort, Gastrointestinal Motility Disorder, Nausea, Dyspepsia, Memory Impairment, Depression, Gastrointestinal Injury
Drug(s) suspected as cause:
Cyclosporine
Dosage: unk ukn, unk
Myfortic
Prednisone
Dosage: unk ukn, unk
Possible Prednisone side effects in male
Reported by a consumer/non-health professional from Brazil on 2012-07-31
Patient: male
Reactions: Abdominal Discomfort, Gastrointestinal Motility Disorder, Nausea, Dyspepsia, Memory Impairment, Depression, Gastrointestinal Injury
Drug(s) suspected as cause:
Cyclosporine
Dosage: unk ukn, unk
Myfortic
Prednisone
Dosage: unk ukn, unk
Possible Prednisone side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-30
Patient: female, weighing 79.4 kg (174.6 pounds)
Reactions: Back Pain, Contusion, Spinal Pain, Nausea, Pain in Extremity, Headache, Gastric Disorder, Somnolence, Fall, Erythema, Rheumatoid Arthritis, Fatigue, Diarrhoea, Impaired Healing, Oedema Peripheral, Spinal Disorder, Infusion Related Reaction
Drug(s) suspected as cause:
Prednisone
Administration route: Oral
Indication: Rheumatoid Arthritis
End date: 2012-01-01
Prednisone
Administration route: Oral
Start date: 2012-01-01
Remicade
Start date: 2012-05-25
Remicade
Indication: Rheumatoid Arthritis
Start date: 2012-07-06
Remicade
Start date: 2012-01-01
Other drugs received by patient: Albuterol Sulphate; Omega 3-6-9; Aspirin; Flonase; Lyrica; Levothyroxine Sodium; Tramadol Hydrochloride; Levothyroxine Sodium; Hydrochlorothiazide; Lidoderm; Lutein; Omeprazole; Flonase; Vitamin B Complex CAP; Albuterol Sulphate; Multi-Vitamins; Cyclobenazprine; Hydrocodone Bitartrate
Possible Prednisone side effects in female
Reported by a physician from Germany on 2012-07-27
Patient: female
Reactions: Vomiting, Nausea, Hyponatraemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1027.5 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-07-04
End date: 2012-07-04
Doxorubicin Hydrochloride
Dosage: 66.5 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-07-04
End date: 2012-07-04
Pegfilgrastim
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-07-08
End date: 2012-07-08
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-07-03
End date: 2012-07-08
Rituximab
Dosage: 513.75 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-07-04
End date: 2012-07-04
Vincristine
Dosage: 2.76 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-07-04
End date: 2012-07-04
Other drugs received by patient: Allopurinol; Amlodipine Besylate; Losartan Potassium; Pantoprazole Sodium; Metoclopramide; Bisoprolol Fumarate
Possible Prednisone side effects in 51 year old male
Reported by a physician from Germany on 2012-07-27
Patient: 51 year old male, weighing 113.0 kg (248.6 pounds)
Reactions: Nausea, Hypotension, Gastritis, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cabazitaxel
Start date: 2012-03-29
End date: 2012-03-29
Cabazitaxel
Start date: 2012-01-19
End date: 2012-01-19
Prednisone
Administration route: Oral
Start date: 2012-01-19
End date: 2012-04-04
Other drugs received by patient: Pantoprazole; Luteinizing Hormone-Releasing Hormone; Amiodarone HCL; Enoxaparin Sodium; Bisoprolol Fumarate; Pravastatin; Simvastatin
Possible Prednisone side effects in female
Reported by a physician from United States on 2012-07-26
Patient: female, weighing 50.6 kg (111.3 pounds)
Reactions: Nausea, Urinary Tract Infection, Cytomegalovirus Viraemia, Rhinorrhoea, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bactrim
Indication: Prophylaxis
Mycophenolate Mofetil
Dosage: unk
Administration route: Oral
Start date: 2011-05-16
End date: 2011-06-04
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-08-24
End date: 2011-05-16
Prednisone
Dosage: 5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-10-23
Prograf
Dosage: 4 mg am, 5 mg pm
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-12-09
End date: 2011-05-16
Prograf
Dosage: 2 mg, bid
Administration route: Oral
Start date: 2011-05-16
Other drugs received by patient: Losartan Potassium; Lasix
Possible Prednisone side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-26
Patient: female
Reactions: Off Label Use, Nausea
Drug(s) suspected as cause:
Colcrys
Administration route: Oral
Indication: Behcet's Syndrome
Start date: 2012-03-27
Prednisone
Administration route: Oral
Indication: Autoimmune Disorder
Start date: 2012-04-02
Prednisone
Administration route: Oral
Start date: 2012-03-28
End date: 2012-03-30
Prednisone
Administration route: Oral
Start date: 2012-03-31
End date: 2012-04-01
Other drugs received by patient: Claritin (Childrens)
Possible Prednisone side effects in male
Reported by a physician from Brazil on 2012-07-26
Patient: male
Reactions: Nausea, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased
Drug(s) suspected as cause:
Acetaminophen
Dosage: unk
Indication: Headache
Start date: 2010-12-13
Acyclovir
Dosage: 4000 unk, unk
Indication: Herpes Zoster
Start date: 2010-12-18
End date: 2010-12-25
Azithromycin
Dosage: 1500 unk, unk
Indication: Prophylaxis
Start date: 2010-11-04
Bactrim
Dosage: 400 mg, unk
Indication: Prophylaxis
Start date: 2010-12-13
Efavirenz
Dosage: unk
Indication: HIV Infection
Start date: 2010-11-25
End date: 2011-01-01
Efavirenz
Dosage: unk
Ethambutol Hydrochloride
Dosage: unk
Indication: Tuberculosis
Start date: 2010-10-16
End date: 2010-12-27
Ethambutol Hydrochloride
Dosage: unk
Isoniazid
Dosage: unk
Indication: Tuberculosis
Start date: 2010-10-16
End date: 2011-01-01
Lamivudine
Dosage: 300 mg, qd
Indication: HIV Infection
Start date: 2010-11-25
Prednisone
Dosage: 40 mg, unk
Indication: Meningitis
Start date: 2010-10-16
Pyrazinamide
Dosage: 1200 mg, unk
Indication: Tuberculosis
Start date: 2010-10-16
End date: 2010-12-27
Rifampin
Dosage: 450 mg, qd
Indication: Tuberculosis
Start date: 2010-10-16
End date: 2011-01-01
Rifampin
Dosage: 450 mg, qd
Tenofovir Disoproxil Fumarate
Indication: HIV Infection
Possible Prednisone side effects in male
Reported by a physician from Poland on 2012-07-26
Patient: male, weighing 72.0 kg (158.4 pounds)
Reactions: Neurotoxicity, Abdominal Pain, Basal Cell Carcinoma, Squamous Cell Carcinoma, Nausea, Toxicity To Various Agents, Blood Creatinine Increased
Drug(s) suspected as cause:
Azathioprine
Dosage: 50 mg a day
Administration route: Oral
Indication: Immunosuppression
Start date: 2000-12-15
End date: 2007-01-18
Myfortic
Dosage: 1080 mg per day
Indication: Immunosuppression
Start date: 2007-02-02
End date: 2009-03-12
Myfortic
Dosage: 360 mg, tid
Administration route: Oral
Start date: 2011-11-17
End date: 2011-12-14
Myfortic
Dosage: 1440 mg a day
Neoral
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2007-01-19
End date: 2007-12-20
Neoral
Dosage: 75 mg, unk
Administration route: Oral
End date: 2011-11-17
Neoral
Dosage: 150 mg and 200 mg
Administration route: Oral
Indication: Immunosuppression
Start date: 2000-12-15
End date: 2007-01-18
Prednisone
Dosage: 5 mg a day
Administration route: Oral
Start date: 2007-12-21
Prednisone
Dosage: 7.5 mg a day
Administration route: Oral
Indication: Immunosuppression
Start date: 2000-12-15
End date: 2007-12-20
Other drugs received by patient: Steroids NOS; Simvastatin; Cellcept; Omeprazole; Iporel; Antihypertensive Drugs; Amlozek; Bisoprolol Fumarate; Polprazol
Possible Prednisone side effects in 21 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient: 21 year old female
Reactions: Hyperbilirubinaemia, Nausea, Malnutrition, Hyperglycaemia, Abdominal Pain Upper, Hepatic Steatosis, Cholelithiasis, Fatigue, Hepatotoxicity, Cholangitis, Pancreatitis, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Daunorubicin HCL
Dosage: unspecified dosage modification
Indication: Acute Lymphocytic Leukaemia
Pegaspargase
Dosage: unspecified dosage modification
Indication: Acute Lymphocytic Leukaemia
Prednisone
Dosage: unspecified dosage modification
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: unspecified dosage modification
Indication: Acute Lymphocytic Leukaemia
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-07-25
Patient: male, weighing 89.7 kg (197.3 pounds)
Reactions: Dyspnoea, Syncope, Fatigue, Diarrhoea, Nausea, Wheezing, Hypoxia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amoxicillin
Indication: Product Used FOR Unknown Indication
Avastin
Dosage: over 30 - 90 minutes on day 1
Indication: Prostate Cancer
Start date: 2010-07-27
Docetaxel
Dosage: over 60 minutes on day 1
Indication: Prostate Cancer
Start date: 2010-07-27
Lenalidomide
Dosage: on day 1 - 14
Administration route: Oral
Indication: Prostate Cancer
Start date: 2010-07-27
Prednisone
Administration route: Oral
Indication: Prostate Cancer
Start date: 2010-07-27
Possible Prednisone side effects in female
Reported by a physician from Germany on 2012-07-24
Patient: female
Reactions: Vomiting, Nausea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Allopurinol
Dosage: 150 mg, qd
Start date: 2012-06-18
Cyclophosphamide
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-07-04
End date: 2012-07-04
Doxorubicin HCL
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-07-04
End date: 2012-07-04
Pegfilgrastim
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-07-08
End date: 2012-07-08
Prednisone
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-07-04
End date: 2012-07-04
Rituximab
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-07-07
End date: 2012-07-07
Vincristine
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-07-04
End date: 2012-07-04
Other drugs received by patient: Losartan Potassium; Bisoprolol Fumarate
Possible Prednisone side effects in
Reported by a consumer/non-health professional from United States on 2012-07-24
Patient:
Reactions: Product Quality Issue, Drug Ineffective, Nausea, Condition Aggravated
Drug(s) suspected as cause:
Prednisone
Possible Prednisone side effects in 72 year old female
Reported by a physician from Canada on 2012-07-24
Patient: 72 year old female
Reactions: Abdominal Pain, Weight Decreased, Vomiting, Tinnitus, Nausea, Urinary Tract Infection, Bursitis, Wound Complication, Haemoglobin Decreased, Diarrhoea, Visual Impairment, Onychoclasis, Sleep Apnoea Syndrome, Asthenia, Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arava
Cymbalta
Dilaudid
Lyrica
Dosage: also taken 150mg
Orencia
Dosage: last dose20oct11,15dec11,16dec11,7feb12,6mar12,13jul12 inf:11,57-500mg-also every 4 week,exp:ma2014
Indication: Rheumatoid Arthritis
Start date: 2011-08-01
Prednisone
Dosage: also taken 15 mg
Other drugs received by patient: Nexium; Pramipexole Dihydrochloride; Amiloride Hydrochloride; Alendronate Sodium; Oxybutynin; Naproxen; Atenolol; Acetaminophen; Calcium; Calcitonin Salmon; Hydromorphone HCL
Possible Prednisone side effects in 21 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: 21 year old female
Reactions: Hyperbilirubinaemia, Fatigue, Nausea, Hyperglycaemia, Asthenia, Abdominal Pain Upper
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Asparaginase
Indication: Acute Lymphocytic Leukaemia
Prednisone
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Vincristine; Daunorubicin HCL
Possible Prednisone side effects in female
Reported by a physician from United States on 2012-07-24
Patient: female, weighing 51.4 kg (113.1 pounds)
Reactions: Nausea, Urinary Tract Infection, Rhinorrhoea, Cytomegalovirus Viraemia, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bactrim
Indication: Prophylaxis
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
End date: 2011-05-16
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
Start date: 2011-05-16
End date: 2011-06-04
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-08-24
End date: 2011-05-04
Prednisone
Dosage: 5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-10-23
Prograf
Dosage: 4 mg am, 5 mg pm
Administration route: Oral
End date: 2011-05-16
Prograf
Dosage: 2 mg, bid
Administration route: Oral
Start date: 2011-05-24
Prograf
Dosage: 4 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-12-09
Prograf
Dosage: unk
Administration route: Oral
Start date: 2011-05-16
Other drugs received by patient: Losartan Potassium; Lasix
Possible Prednisone side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-23
Patient: female, weighing 79.4 kg (174.6 pounds)
Reactions: Spinal Pain, Contusion, Nausea, Headache, Erythema, Somnolence, Fall, Gastric Disorder, Fatigue, Impaired Healing, Oedema Peripheral, Infusion Related Reaction
Drug(s) suspected as cause:
Prednisone
Administration route: Oral
Indication: Rheumatoid Arthritis
End date: 2012-01-01
Prednisone
Administration route: Oral
Start date: 2012-01-01
Remicade
Indication: Rheumatoid Arthritis
Start date: 2012-05-25
Remicade
Start date: 2012-01-01
Other drugs received by patient: Levothyroxine Sodium; Levothyroxine Sodium; Hydrochlorothiazide; Lutein; Aspirin; Omeprazole; Flonase; Lidoderm; Tramadol Hydrochloride; Lyrica; Cyclobenazprine; Albuterol Sulphate; Vitamin B Complex CAP; Hydrocodone; Flonase; Multi-Vitamins; Omega 3-6-9; Albuterol Sulphate
Possible Prednisone side effects in female
Reported by a physician from United States on 2012-07-20
Patient: female, weighing 55.0 kg (121.0 pounds)
Reactions: Hyperaesthesia, Diarrhoea, Nausea, Haemoglobin Abnormal, Immunosuppressant Drug Level Increased, Blood Creatinine Increased, Micturition Urgency
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-10-19
End date: 2011-12-15
Prednisone
Dosage: 5 mg, cyclic
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-10-19
End date: 2011-12-15
Rituximab
Dosage: 314 mg, cyclic
Indication: Renal Transplant
Start date: 2011-10-20
End date: 2011-10-20
Tacrolimus
Dosage: 12 mg, cyclic
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-10-21
End date: 2011-12-15
Thymoglobulin
Dosage: 100 mg, cyclic
Indication: Renal Transplant
Start date: 2011-10-19
End date: 2011-10-25
Velcade
Dosage: 2 mg, cyclic
Indication: Renal Transplant
Start date: 2011-10-19
End date: 2011-10-29
Other drugs received by patient: Nystatin; Albuterol; Colace; Bactrim; Coreg; Vitamin D; Synthroid; Topamax; Vitamin B-12; Miralax / 00754501 /; Percocet; Valcyte; Pepcid; Plaquenil
Possible Prednisone side effects in 53 year old male
Reported by a consumer/non-health professional from United States on 2012-07-18
Patient: 53 year old male, weighing 143.0 kg (314.6 pounds)
Reactions: Nausea, Visual Impairment, Feeling Abnormal, Asthenia, Nervousness
Drug(s) suspected as cause:
Prednisone
Indication: Haematoma
Warfarin Sodium
Possible Prednisone side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-12
Patient: 67 year old male, weighing 78.0 kg (171.6 pounds)
Reactions: Multi-Organ Failure, Spinal Pain, Nausea, Sepsis, Febrile Neutropenia, Dizziness, Hepatitis B, Cough
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: .25 milligram/kilogram
Indication: Multiple Myeloma
Start date: 2009-01-29
End date: 2009-02-02
Prednisone
Dosage: 2 milligram
Indication: Multiple Myeloma
Start date: 2009-01-29
End date: 2009-02-02
Thalidomide
Dosage: 200 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-01-29
End date: 2009-02-10
Other drugs received by patient: Kalium; Metamizol; Levothyroxine Sodium; Lactulose; Tramadol HCL; Nadroparin; Pantoprazole; Tamsulosin HCL; Allopurinol; Aspirin; Amphotericin B; Nadroparin
Possible Prednisone side effects in 83 year old male
Reported by a consumer/non-health professional from United States on 2012-07-09
Patient: 83 year old male, weighing 82.6 kg (181.6 pounds)
Reactions: White Blood Cell Count Decreased, Vomiting, Fatigue, Diarrhoea, Nausea, Pain, Muscle Spasms
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone
Other drugs received by patient: Taxotere; ^too Many^ Unspecified Concomitant Medications
Possible Prednisone side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-06
Patient: female, weighing 52.2 kg (114.8 pounds)
Reactions: Agitation, Contusion, Upper Limb Fracture, Coma, Chronic Obstructive Pulmonary Disease, Rheumatoid Arthritis, Malaise, Oedema Peripheral, Skin Atrophy, Ultrasound Kidney Abnormal, Vein Disorder, Cellulitis, Drug Withdrawal Syndrome, Convulsion, Anaemia of Chronic Disease, Enterococcus Test Positive, Fall, Skin Discolouration, Postoperative Wound Complication, Pleural Effusion, Gastrooesophageal Reflux Disease, Pathogen Resistance, Decreased Appetite, Renal Failure Acute, Fluid Overload, Nausea, Urinary Tract Infection, Condition Aggravated, Atrial Fibrillation, Nosocomial Infection, Heart Rate Increased, Sepsis, Hypothyroidism, Asthenia, Antibiotic Level Above Therapeutic
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone
Dosage: 5 mg;qd;po
Administration route: Oral
Indication: Rheumatoid Arthritis
Vancomycin
Dosage: iv
Indication: Cellulitis
Other drugs received by patient: Aspirin; Methocarbamol; Spiriva; Levothyroxine Sodium; Ondansetron; Forteo; Oxycontin; Diltiazem; Hydroxychloroquine Sulfate; Erythromycin; Advair Diskus 100 / 50
Possible Prednisone side effects in female
Reported by a physician from Canada on 2012-07-05
Patient: female, weighing 48.1 kg (105.9 pounds)
Reactions: Eyelid Oedema, Vomiting, Pruritus, Nausea, Pain, Skin Burning Sensation, Herpes Zoster, Herpes Simplex, Herpes Zoster Ophthalmic
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acyclovir
Indication: Product Used FOR Unknown Indication
Humira
Start date: 2012-05-30
End date: 2012-06-15
Humira
Start date: 2012-03-13
End date: 2012-03-13
Humira
Dosage: 160 mg on 25-apr-2012 and 80 mg on 13-may-2012
Indication: Crohn's Disease
Start date: 2012-04-25
End date: 2012-04-25
Prednisone
Administration route: Oral
Indication: Crohn's Disease
Start date: 2012-03-29
End date: 2012-05-17
Other drugs received by patient: Lyrica; Vitamin D; Nicotine; Mesalamine; Calcium
Possible Prednisone side effects in
Reported by a physician from United States on 2012-07-05
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Dyspnoea, Stomatitis, Vomiting, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Prednisone
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Prednisone
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Other drugs received by patient: Filgrastim; Unknown Medication; Leucovorin Calcium
Page 1 Next >>
|
